Regeneron Pharmaceuticals (REGN) Long-Term Debt Issuances (2009 - 2010)
Regeneron Pharmaceuticals (REGN) recorded quarterly Long-Term Debt Issuances of $47.5 million in Q1 2010, up 157.58% quarter-over-quarter from $18.5 million in Q4 2009.
Regeneron Pharmaceuticals (REGN) Long-Term Debt Issuances (2009 - 2010) Analysis & Trends
Regeneron Pharmaceuticals' Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $47.5 million for Q1 2010.
- In Q1 2010, Long-Term Debt Issuances changed N/A year-over-year to $47.5 million; the TTM figure through Dec 2010 stood at $47.5 million (changed N/A YoY), while the FY2020 annual figure was $2.0 billion, changed N/A from the prior year.
- Long-Term Debt Issuances was $47.5 million for Q1 2010 at Regeneron Pharmaceuticals, up from $18.5 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $47.5 million in Q1 2010 to a low of $18.5 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.73 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | 47.54 Mn |
| Mar 31, 2010 | 47.54 Mn |
| Dec 31, 2009 | 18.46 Mn |
| Dec 31, 2009 | 18.46 Mn |